Skip to main content
ConductScienceScienceDex

Leopoldo Nicolas Segal

NIH Rank #5592
Unclaimed recordClaim profile
  • Program Leader
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10753377Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$2M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#5,592
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Leopoldo Nicolas Segal. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Leopoldo Nicolas Segal as a PI. Multi-PI records show the full award amount for context.

  • 4R33GM147800-03R33
    BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS
    NYU Grossman School of Medicine
    $743.7K
    award amount
  • 5R37CA244775-05R37
    Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
    NYU Grossman School of Medicine
    $596.6K
    award amount
  • 1U01AG088351-01U01
    Age related loss of immune resilience during response to severe respiratory viral infections
    NYU Grossman School of Medicine
    $528K
    award amount
  • 5U2CCA271890-02U2C
    Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
    NYU Grossman School of Medicine
    $85.4K
    award amount

Award organization

Organizations that administered FY2024 awards listing Leopoldo Nicolas Segal as a PI.

FY2024 award administered by NYU Grossman School of Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5592
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Program/Center Grant Leader
  7. 2026
    $5M Cumulative Funding
  8. 2026
    Entered Top 25% Nationally
    Ranked #3633

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Leopoldo Nicolas Segal.

Bin Zhang
NYU Grossman School of Medicine
3
shared awards
Christian Forst
NYU Grossman School of Medicine
3
shared awards
Harvey Ira Pass
NYU Grossman School of Medicine
3
shared awards
Kendrew King Hao Wong
NYU Grossman School of Medicine
1
shared award

Explore further

Find collaborators for Leopoldo Nicolas Segal

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →